Margrave David R. bought LTRN
December 18, 2025 · Form 4 insider transaction
Margrave David R. bought 20,000 shares of Lantern Pharma Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
20,000
Price
$0.00
Total value
N/A
InsiderMargrave David R.
Role—
CompanyLantern Pharma Inc. (LTRN)
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateDecember 18, 2025
Filing dateDecember 22, 2025
Shares owned after20,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 24-month period commencing January 18, 2026.